TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MGX

Metagenomi, Inc.

Healthcare · Biotechnology

1.20$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Metagenomi, Inc. (MGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 221 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MGX
Line item 2021 2022 2023 2024 2025
142 414 365 325 221
109 367 278 258 166
39 184 141 27 42
108 362 271 248 161
0.5 1.3 2.5 1.3 0.3
175 489 500 90 63
25 49 69 37 23
0.7 1.5 3.4 5.6 6.0
1.4 2.0 1.8 0.5 1.5
30 – – – –
-33 -74 -136 235 159
-33 -77 -145 -223 -311
5.9 37 37 37 37

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?